1-13 of 13
Justyna Rybka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: First Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

Krzysztof Jamroziak, Elzbieta Iskierka-Jazdzewska, Sebastian Giebel, Kamil Wisniewski, Joanna Drozd-Sokolowska, Tadeusz Robak, Justyna Rybka, Weronika Piszczek, Monika Joks, Anna Paulina Dabrowska-Iwanicka, Andrzej Mital, Paweł Steckiewicz, Ewa Lech-Maranda, Marcin Jasinski, Marcin Rymko, Dawid Marciniak, Tomasz Wrobel, Lidia Gil, Joanna Romejko-Jarosinska, Dorota Kruk-Kwapisz, Agnieszka Chudy, Krzysztof Giannopoulos, Tomasz Stoklosa, Bartosz Michal Pula
Journal: Blood
Blood (2024) 144 (Supplement 1): 3242.
https://doi.org/10.1182/blood-2024-201076
Published: 2024
Journal Articles

Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wrobel, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Justyna Rybka, Maciej Majcherek, Lidia Usnarska-Zubkiewicz, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Dorota Kruk-Kwapisz, Oscar Boutros Lahoud, Jeffrey A. Zonder, Kent Griffith, Andrew T Stefka, Ken Jiang, Jennifer H Cooperrider, Ben A Derman, Andrzej J Jakubowiak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4715.
https://doi.org/10.1182/blood-2023-189850
Published: 2023
Journal Articles

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study

Agnieszka Wierzbowska, Agnieszka Pluta, Piotr Stelmach, Kamil Brzozowski, Magdalena Czemerska, Marta Sobas, Justyna Rybka, Tomasz Wróbel, Ewa Zarzycka, Witold Prejzner, Jan M. Zaucha, Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel
Journal: Blood
Blood (2023) 142 (Supplement 1): 5914.
https://doi.org/10.1182/blood-2023-181633
Published: 2023
Journal Articles

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Agnieszka Wierzbowska, Agnieszka Pluta, Piotr Stelmach, Marta Anna Sobas, Justyna Rybka, Tomasz Wróbel, Ewa Zarzycka, Witold Prejzner, Jan Zaucha, Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel
Journal: Blood
Blood (2022) 140 (Supplement 1): 6165–6166.
https://doi.org/10.1182/blood-2022-163109
Published: 2022
Journal Articles

Analysis of Polymorphism in the Genes TLR3, TLR4 and TLR9 in Patients with Acute Myeloid Leukemia

Justyna Rybka, Katarzyna Bogunia-Kubik, Bartłomiej Kuszczak, Elżbieta Kalicińska, Piotr Łacina, Marta Dratwa, Tomasz Wróbel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4470.
https://doi.org/10.1182/blood-2021-151475
Published: 2021
Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, MBBS, FRACP, FRCPA, PhD, Hartmut Döhner, MD, Christopher Pocock, MBBS, Pau Montesinos, MD PhD, Boris Afanasyev, MD DSci, Hervé Dombret, MD, Farhad Ravandi, MD, Hamid Sayar, MD MSc, Jun Ho Jang, MD PhD, Kimmo Porkka, MD, Dominik Selleslag, MD, Irwindeep Sandhu, MD, Mehmet Turgut, MD, Valentina Giai, MD, Yishai Ofran, MD, Merih Kizil Cakar, MD, Aida Botelho de Sousa, MD, Justyna Rybka, MD PhD, Chiara Frairia, MD, Lorenza Borin, MD, Germana Beltrami, MD, Jaroslav Cermak, MD PhD, Gert J. Ossenkoppele, MD PhD, Ignazia La Torre, MD, Barry Skikne, MD, Keshava Kumar, PhD, Qian Dong, DrPH, CL Beach, PharmD, Gail J. Roboz, MD
Journal: Blood
Blood (2019) 134 (Supplement_2): LBA-3.
https://doi.org/10.1182/blood-2019-132405
Published: 2019
Journal Articles

Improved Treatment Outcomes for Patients with Hodgkin Lymphoma Relapsing after Autologous Hematopoietic Stem Cell Transplantation in the Brentuximab Vedotin Era - the Real-Life Report from the Polish Lymphoma Research Group

Anna Czyz, MD PhD, Anna Lojko-Dankowska, MD PhD, Agnieszka Giza, MD PhD, Monika Dlugosz-Danecka, MD PhD, Wojciech Jurczak, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Ewa Paszkiewicz, MD PhD, Justyna Rybka, MD PhD, Joanna Drozd-Sokolowska, MD PhD, Edyta Subocz, MD PhD, Tomasz Czerw, MD PhD, Barbara Nasilowska-Adamska, MD PhD, Agnieszka Kolkowska, MD PhD, Manko Joanna, MD PhD, Dorota Hawrylecka, MD PhD, Wanda Knopinska-Posluszny, MD PhD, Szymanska Agata, MD PhD, Lidia Gil, MD PhD, Mieczyslaw Komarnicki, MD PhD, Marek Hus, MD PhD, Jan Walewski, MD PhD, Sebastian Giebel, MD PhD, Tomasz Wrobel, MD PhD, Jan Zaucha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5276.
https://doi.org/10.1182/blood-2019-130484
Published: 2019
Journal Articles

Brentuximab Vedotin Alone and in Combination with Bendamustine As Salvage Therapy for Primary Refractory or Relapsed Hodgkin Lymphoma: Multicentre Experience of the Polish Lymphoma Research Group (PLRG)

Anna Czyz, MD PhD, Anna Lojko-Dankowska, Monika Joks, MD, Mieczyslaw Komarnicki, MD PhD, Monika Dlugosz-Danecka, MD PhD, Wojciech Jurczak, Justyna Rybka, MD PhD, Tomasz Wrobel, MD PhD, Ewa Paszkiewicz, Jan Walewski, MD, Dorota Hawrylecka, Joanna Drozd-Sokolowska, MD PhD, Edyta Subocz, Szymanska Agata, Magdalena Witkowska, Piotr Smolewski, MD PhD, Agnieszka Kolkowska, Ewa Lech Maranda, Wanda Knopinska-Posluszny, Sebastian Giebel, Jan Zaucha, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5375.
https://doi.org/10.1182/blood-2018-99-116610
Published: 2018
Journal Articles

Long-Term Evaluation of Efficacy and Safety of Ofatumumab Added to Fludarabine & Cyclophosphamide in Subjects with Relapsed Chronic Lymphocytic Leukemia: Final Analysis of Complement 2 Trial

Sebastian Grosicki, MD PhD, Ewa Lech-Maranda, MD PhD, K Govind Babu, MD DM, Justyna Rybka, MD PhD, Elena Litvinskaya, PhD, Javier Loscertales, MD, Irina Kryachok, Prof., PhD, Janusz Kłoczko, Prof., PhD, Grygoriy Rekhtman, MD, Wojciech Homenda, MD PhD, Jerzy Blonski, MD PhD, Tommaso Stefanelli, Ghislaine Vincent, Hiya Banerjee, Tadeusz Robak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2018-99-112139
Published: 2018
Journal Articles

Preemptive Daratumumab Therapy for Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma: Rationale and Design of the Polish Myeloma Consortium Predator Study

Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wrobel, MD PhD, Adam Nowicki, Bartosz Pula, Norbert Grząśko, Justyna Rybka, Paweł J. Robak, MD, Agnieszka Druzd-Sitek, Adam Walter-Croneck, Katarzyna Brzeźniakiewicz-Janus, MDPhD, Jarosław Czyż, Krzysztof Warzocha, Dominik Dytfeld
Journal: Blood
Blood (2017) 130 (Supplement 1): 5404.
https://doi.org/10.1182/blood.V130.Suppl_1.5404.5404
Published: 2017
Journal Articles

The Prognostic Role of Interim PET after First Chemotherapy Cycle and PET Sequential Evaluation of Response to ABVD in Hodgkin Lymphoma Patients - the Polish Lymphoma Research Group (PLRG) Observational Study

Jan M Zaucha, MD PhD, Bogdan Malkowski, MD, Edyta Subocz, MD, Stephane Chauvie, PhD, Joanna Tajer, MD, Waldemar Kulikowski, MD, Agnieszka Fijolek-Warszewska, MD, Alberto Biggi, MD, Federico Fallanca, MD, Malgorzata Kobylecka, MD, Miroslaw Dziuk, MD PhD, Dariusz Woszczyk, MD, Justyna Rybka, MD, Renata Kroll-Balcerzak, MD, Fabrizio Bergesio, PhD, Agnieszka Romanowicz, MD, Agnieszka Chamier-Cieminska, MD, Pawel Kurczab, MD, Agnieszka Giza, Krzysztof Lesniewski-Kmak, MD, Wanda Knopinska-Posluszny, MD PhD, Jan Walewski, MDPhDProf, Andrea Gallamini, MD
Journal: Blood
Blood (2015) 126 (23): 3943.
https://doi.org/10.1182/blood.V126.23.3943.3943
Published: 2015
Journal Articles

Cladribine Added to Daunorubicin and Cytarabine Induction Regimen Prolongs Survival of Patients with Complex but Not Monosomal Karyotype Acute Myeloid Leukemia – Retrospective Analysis of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, MD PhD, Ewa Wawrzyniak, PhD, Monika Siemieniuk-Rys, MSc, Aleksandra Kotkowska, PhD, Agnieszka Pluta, MD PhD, Tadeusz Robak, MD, Anna Jaskowiec, MSc, Ewa Duszenko, MSc, Marta Szarawarska, MSc, Justyna Rybka, MD PhD, Jadwiga Holojda, MD, Sebastian Grosicki, MD, Barbara Pienkowska-Grela, PhD, Renata Woroniecka, PhD, Anna Ejduk, MDPhD, Marzena Watek, MD, Malgorzata Wach, MDPhD, Barbara Mucha, PhD, Katarzyna Skonieczka, PhD, Maria Czyzewska, MD, Anna Jachalska, MD, Agnieszka Klonowska, MSc, Mariola Iliszko, PhD, Wanda Knopinska-Posluszny, Malgorzata Jarmuz-Szymczak, PhD, Anna Przybylowicz-Chalecka, MSc, Lidia Gil, MD PhD, Agnieszka Kopacz, MD, Jerzy Holowiecki, MD PhD, Olga Haus, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2347.
https://doi.org/10.1182/blood.V124.21.2347.2347
Published: 2014
Journal Articles

High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)

Aleksandra Butrym, MD PhD, Dagmara Baczynska, PhD, Andrzej Tukiendorf, Prof., Justyna Rybka, MD PhD, Tadeusz Dobosz, Prof., Wojciech Jurczak, Kazimierz Kuliczkowski, MD PhD Prof., Grzegorz Mazur, Prof.
Journal: Blood
Blood (2014) 124 (21): 5330.
https://doi.org/10.1182/blood.V124.21.5330.5330
Published: 2014